Peripheral blood leukocyte production of BDNF following mitogen stimulation in early onset and regressive autism

American Journal of Biochemistry and Biotechnology

Volumn 4, Issue 2, 2008, Pages 121-129

  Enstrom, Amanda ^a   Onore, Charity ^a   Tarver, Angela ^a   Hertz Picciotto, Irva ^a   Hansen, Robin ^b   Croen, Lisa ^c   Van De Water, Judy ^b   Ashwood, Paul ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DIVISION OF RESEARCH   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autism; Brain derived neurotrophic factor (BDNF); Inflammation; Luminex; Neurotrophin

Indexed keywords

CELLS; DIAGNOSIS; IMMUNOLOGY; MEDICAL PROBLEMS;

AUTISM; BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF); LUMINEX; NEUROTROPHIN;

BLOOD;

BRAIN DERIVED NEUROTROPHIC FACTOR; LIPOPOLYSACCHARIDE; MITOGENIC AGENT; PHYTOHEMAGGLUTININ; TETANUS TOXOID;

ARTICLE; AUTISM; CELL STIMULATION; CHILD DEVELOPMENT; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; LEUKOCYTE; LEUKOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; NERVOUS SYSTEM DEVELOPMENT; ONSET AGE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS REGULATION;

EID: 42449113260     PISSN: 15533468     EISSN: None     Source Type: Journal    
DOI: 10.3844/ajbbsp.2008.121.129     Document Type: Article

References (56)

1. Goldberg, W., K. Osann, P. Filipek, T. Laulhere, K. Jarvis, C. Modahl, P. Flodman and M.A. Spence, 2000. Language and other regression: assessment and timing. J. Autism Develop. Disord., 33: 607-616.
2. Murphy, M., P.F. Bolton, A. Pickles, E. Fombonne, J. Piven and M. Rutter, 2000. Personality traits of the relatives of autistic probands. Physcholog.l Med., 30: 1411-1424.
3. Micali, N., S. Chakrabarti and E. Fombonne, 2004. The broad autism phenotype - finding from an epidemiological survey. Autism, 8: 21-37.
4. Yirmiya, N. and M. Shaked, 2005. Psychiatric disorders in parents of children with autism: A meta-analysis. J. Child Physchol. Physch., 46: 69-83.
5. Polleux, F. and J.M. Lauder, 2004. Toward a developmental neurobiology of autism. Ment. Retard. Dev. Disabil. Res. Rev., 10: 303-317.
6. Burger, R.A. and R.P. Warren, 1998. Possible immunogenetic basis for autism. Ment. Retard. Dev. Disabil. Res. Rev., 4: 137-141.
7. Campbell, D.B., J.S. Sutcliffe, P.J. Ebert, R. Milterni, C. Bravacci, S. Trillo, M. Elia, C. Schneider, R. Melmed, R. Sacco, A.M. Perisco and P. Levitt, 2006. A genetic variant that disrupts MET transcription is associated with autism. Proc. Natl. Acad. Sci., 103: 16834-16839.
8. Skaar, D.A., Y. Shao, J.L. Haines, J.E. Stenger, J. Jaworski, E.R. Martin, G.R. DeLong, J.H. Moore, J.L. McCauley, J.S. Sutcliffe, A.E. Ashley-Koch, M.L. Cuccaro, S.E. Folstein, J.R. Gilbert and M.A. Pericak-Vance, 2005. Analysis of the RELN gene as a genetic risk factor for autism. Mol. Psychiatry, 10: 563-571.
9. The autism project consortium, 2007. Mapping autism risk loci using genetic linkage and chromosome rearrangements. Nat. Gen., 39: 319-328.
10. Mutter, J., J. Naumann, R. Schneider, H. Walach and B. Haley, 2005. Mercury and autism: accelerating evidence? Neuroendocrinol. Lett., 26: 439-446.
11. Windham, G., L. Zhang, R. Gunier, L.A. Croen and J.K. Grether, 2006. Autism spectrum disorders in relation to distribution of hazardous air pollutants in the San Francisco Bay Area. Environ. Health Perpect., 114: 1438-1444.
12. Libbey, J.E., T.L. Sweeten, W.M. McMahon and R.S. Fujinami, 2005. Autistic disorder and viral infections. J. Neurovirol. 11: 1-10.
13. Ashwood, P., S. Wills and J. Van De Water, 2006. The immune response in autism: a new frontier for autism research. J. Leukocyte Biol., 80: 1-15.
14. Bessis, A., C. Bechade, D. Bernard and A. Roumier, 2007. Microglial control of neuronal death and synaptic properties. Glia, 55: 233-238.
15. Besser, M. and R. Wank, 1999. Cutting edge: clonally restricted production of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3 mRNA by human immune cells and Th1/Th2-polarized expression of their receptors. J. Immunol., 162: 6303-6306.
16. Cook, E.H., R. Courchesne, C. Lord, N.J. Cox, S. Yan, A. Lincoln, R. Haas, E. Courchesne and B.L. Leventhal, 1997. Evidence of linkage between the serotonin transporter and autistic disorder. Mol. Psychiatry, 2: 247-250.
17. Devlin, B., E.H. Cook, H. Coon, G. Dawson, E.L. Grigorenko, W. McMahon, N. Minshew, D. Pauls, M. Smith, M.A. Spence, P.M. Rodier, C. Stodgell and G.D. Schellenberg, 2005. Autism and the serotonin transporter: The long and short of it. Mol. Psychiatry, 10: 1110-1116.
18. Connors, S.L., K.J. Matteson, G.A. Sega, C.B. Lozzio, R.C. Carroll and A.W. Zimmerman, 2006. Plasma serotonin in autism. Ped. Neurol., 35: 182-186.
19. Monteggia, L.M., B. Luikart, M. Barrot, D. Theobold, I. Malkovska, S. Nef, L.F. Parada and E.J. Nestler, 2007. Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Biol. Psychiatry, 61: 187-197.
20. Chan, J.P., T.J. Unger, J. Byrnes and M. Rios, 2006. Examination of behavioral deficits triggered by targeting BDNF in fetal or postnatal brains of mice. Neuroscience, 142: 49-58.
21. Shimizu, E., K. Hashimoto, N. Okamura, K. Koike, N. Komatsu, C. Kumakiri, M. Nakazato , H. Watanabe, N. Shinoda, S. Okada and M. Iyo, 2003. Alterations on serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol. Psychiatry, 54: 70-75.
22. Machado-Vieira, R., M.O. Dietrich, R. Leke, V.H. Cereser, V. Zanatto, F. Kapczinski, D.O. Souza, L.V. Portela and V. Gentil, 2007. Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode. Biol. Physchiatry, 61: 142-144.
23. Branchi, I., I. D'Andrea, M. Fiore, V. Di Fausto, L. Aloe and E. Alleva, 2006. Early social enrichment shapes social behavior and nerve growth factor and brain-derived neurotrophic factor levels in the adult mouse brain. Biol. Psychiatry, 60: 690-696.
24. Miyazaki, K., N. Narita, R. Sakuta, T. Miyahara, H. Naruse, N. Okado and M. Narita, 2004. Serum neurotrophin concentrations in autism and mental retardation: A pilot study. Brain Devel., 26: 292-295.
25. Nelson, K.B., J.K. Grether, L.A. Croen, J.M. Dambrosia, B.F. Dickens, J.L. Jelliffe, R.L. Hansen and T.M. Phillips, 2001. Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann. Neurol., 49: 597-606.
26. Perry, E.K., M.L.W. Lee, C.M. Martin-Ruiz, J.A. Court, S.G. Volsen, J. Merrit, E. Folly, P.E. Iversen, M.L. Bauman, R.H. Perry and G.L. Wenk, 2001. Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. Am. J. Phychiatry, 158: 1058-1066.
27. Pan, W., W.A. Banks, M.B. Fasold, J. Bluth and A.J. Kastin, 1998. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharm., 37: 1553-1561.
28. Karege, F., M. Schwald and M. Cisse, 2002. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci. Lett., 328: 261-264.
29. Nelson, P.G., T. Kuddo, E.Y. Song, J.M. Dambrosia, S. Kohler, G. Satyanarayana, C. VanDunk, J.K. Grether and K.B. Nelson, 2006. Selected neurotrophins, neuropeptides and cytokines: developmental trajectory and concentrations in neonatal blood of children with autism or Down syndrome. Int. J. Dev. Neurosci., 24: 73-80.
30. Gilmore, J.H., L.F. Jarskog and S. Vadlamudi, 2003. Maternal infection regulates BDNF and NGF expression in fetal and neonatal brain and maternal-fetal unit of the rat. J. Immunol., 138: 49-55.
31. Gilmore, J.H., L.F. Jarskog and S. Vadlamudi, 2005. Maternal poly I:C exposure during pregnancy regulates TNF alpha BDNF and NGF expression in the neonatal brain and maternal-fetal unit of the rat. J. Neuroimmunol., 159: 106-112.
32. Borrell, J., J.M. Vela, A. Arevalo-Marin., E. Molina-Holgado and C. Guaza, 2002. Prenatal immune challenge disrupts sensorimotor gating in adult rats: Implications for the etiopathogenesis of schizophrenia. Neuropsychopharmacol., 26: 204-215.
33. Zuckerman, L., M. Rehavi, R. Nachman and I. Weiner, 2003. Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia. Neuropsychopharmacology, 28: 1778-1789.
34. Shi, L.M., Fatemi H., Sidwell R.W. and Ph. Patterson, 2003. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci. 23: 297-302.
35. Fortier, M.E., R. Joober, G.N. Luheshi and P. Boksa, 2004. Maternal exposure to bacterial endotoxin during pregnancy enhances amphetamine-induced locomotion and startle responses in adult rat offspring. J. Psychiatr., Res., 38: 335-345.
36. Meyer, U., J. Feldon, M. Schedlowski and B.K. Yee, 2006. Immunological stress at the maternalfoetal interface: A link between neurodevelopment and adult psychopathology. Brain Behav. Immun., 20: 378-388.
37. Stadelmann, C., M. Kerschensteiner, T. Misgeld, W. Brück, R. Hohlfeld and H. Lassmann, 2002. BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells? Brain, 125: 75-85.
38. Vargas, D.L., C. Nascimbene, C. Krishnan, A.W. Zimmerman and C.A. Pardo, 2005. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol., 57: 67-81.
39. Deumens, R., G.C. Koopmans, R.J.P. Jaken, K. Morren, T. Comhair, S. Kosar, H.W.M. Steinbusch, D. Bakker and E.A.J. Joosten, 2006. Stimulation of neurite outgrowth on neonatal cerebral astrocytes in enhanced in the presence of BDNF. Neurosci. Lett., 407: 268-273.
40. Kemper, T.L. and M. Bauman, 1998. Neuropathology on infantile autism. J. Neuropath. Exp. Neurol., 57: 645-652.
41. Fatemi, S.H., J. Earle, R. Kanodia, D. Kist, E.S. Emamian, P.H. Patterson, L.M. Shi and R. Sidwell, 2002. Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: Implications for genesis of autism and schizophrenia. Cell Mol. Neurobiol., 22: 25-33.
42. Hertz-Picciotto, I., L.A. Croen, R. Hansen, C.R. Jones, J. Van de Water and I.N. Pessah, 2006. The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism. Env. Health Persp., 114: 1119-1125.
43. Lord, C., A.M. Pickles, J. McLennan, M. Rutter, J. Bregman, S. Folstein, E. Fombonne, M. Leboyer and N. Minshew, 1997. Diagnosing autism: Analyses of data from the autism diagnostic interview. J. Autism Devel. Disord, 27: 501-517.
44. Lord, C., S. Risi, L. Lambrecht, E.H. Cook, B.L. Leventhal, P.C. DiLavore, A. Pickles and M. Rutter, 2000. The autism diagnostic observation schedule-generic: A standard measure of social and communication deficits associated with the spectrum of autism. J. Autism Devel. Disord., 30: 205-223.
45. Lord, C., B.L. Leventhal and E.H. Cook, 2001. Quantifying the phenotype in autism spectrum disorders. Am. J. Med. Genet., 105: 36-38.
46. Joseph, R.M., H. Tager-Flusberg and C. Lord, 2006. Cognitive profiles and social-communicative functioning in children with autism spectrum disorder. J. Child Psychol. Psychiatr. Allied Disciplines, 43: 807-821.
47. Croonenberghs, J., E. Bosmans, D. Deboutte, G. Kenis and M. Maes, 2002. Activation of the inflammatory response system in autism. Neuropsychobiol., 45: 1-6.
48. Jyonouchi H., S.N. Sun and H. Le, 2001. Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J. Neuroimmunol., 120: 170-179.
49. Ashwood, P. and A.J. Wakefield, 2006. Immune activation of peripheral blood and mucosal CD3(+) lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms. J. Neuroimmunol., 173: 126-134.
50. Schulte-Herbruggen, O., C. Nassenstein, M. Lommatzsch, D. Quarcoo, H. Renz and A. Braun, 2005. Tumor necrosis factor-α and interleukin-6 regulate secretion of brain-derived neurotrophic factor in human monocytes. J. Neuroimmunol., 160: 204-209.
51. Aloe, L., F. Properzi, L. Probert, K. Akassoglou, G. Kassiotis, A. Micera and M. Fiore, 1999. Learning abilities, NGF and BDNF brain levels in two lines of TNF-α transgenic mice, one characterized by neurological disorders, the other phenotypically normal. Brain Res., 840: 125-137.
52. Heese, K., C. Hock and U. Otten, 1998. Inflammatory signals induce neurotrophin expression in human microglia cells. J. Neurochem., 70: 699-707.
53. Croll, S.D., C. Suri, D.L. Compton, Simmons M.V., G.D. Yancopoulos, R.M. Lindsay, S.J. Wiegand, J.S. Rudge and H.E. Scharfman, 1999. Brain-derived neurotrophic factor transgenic mice exhibit passive avoidance deficits, increased seizure severity and in vitro hyperexcitability in the hippocampus and entorhinal cortex. Neuroscience, 93: 1491-1506.
54. Nawa, H., M. Takahashi and P.H. Patterson, 2000. Cytokine and growth factor involvement in schizophrenia - support for the developmental model. Mol. Psychiatry, 5: 594-603.
55. Kurtzke, J.F., 1993. Epidemiological evidence for multiple-sclerosis as an infection. Clin. Micro. Rev., 6: 382-427.
56. Sospedra, M. and R. Martin, 2006. Molecular mimicry in multiple sclerosis. Autoimmunity, 39: 3-8.